Preparation and characterization of a VEGF-Fc fusion protein matrix for enhancing HUVEC growth

Biotechnology Letters

Volumn 34, Issue 9, 2012, Pages 1765-1771

  Yu, Meihua ^a   Du, Fengyi ^b   Ise, Hirohiko ^c   Zhao, Wei ^b   Zhang, Yan ^b   Yu, Yaoting ^b   Yao, Fanglian ^a   Yang, Jun ^b   Akaike, Toshihiro ^c  

^a TIANJIN UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Biomaterials; Extracellular matrix; Fusion protein; Growth factor; Vascularization

Indexed keywords

ACTIN FILAMENT; ARTIFICIAL EXTRACELLULAR MATRIXES; EXTRACELLULAR MATRICES; FUSION PROTEINS; GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IMMUNOGLOBULIN G; IN-VIVO; STRESS FIBERS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BIOLOGICAL MATERIALS; BIOMATERIALS; HYDROPHOBICITY; POLYSTYRENES; PROTEINS;

ENDOTHELIAL CELLS;

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; POLYSTYRENE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CHEMICAL PHENOMENA; CHEMISTRY; CULTURE TECHNIQUE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING; TIME;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMMUNOGLOBULIN FC FRAGMENTS; POLYSTYRENES; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865707054     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-012-0959-7     Document Type: Article

References (11)

1. Azuma K, Nagaoka M, Cho CS, Akaike T (2010) An artificial extracellular matrix created by hepatocyte growth factor fused to IgG-Fc. Biomaterials 31(5): 802-809.
2. Chen L, He Z, Chen B, Yang M, Zhao Y, Sun W, Xiao Z, Zhang J, Dai J (2010) Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. J Mater Sci Mater Med 21(1): 309-317.
3. Huang C (2009) Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology. Curr Opin Biotechnol 20(6): 692-699.
4. Nagaoka M, Ise H, Akaike T (2002) Immobilized E-cadherin model can enhance cell attachment and differentiation of primary hepatocytes but not proliferation. Biotechnol Lett 24: 1857-1862.
5. Nagaoka M, Jiang HL, Hoshiba T, Akaike T, Cho CS (2010) Application of recombinant fusion proteins for tissue engineering. Ann Biomed Eng 38(3): 683-693.
6. Novosel EC, Kleinhans C, Klurer PJ (2011) Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 63(4-5): 300-311.
7. Ogiwara K, Nagaoka M, Cho CS, Akaike T (2005) Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc. Biotechnol Lett 27(20): 1633-1637.
8. Shen YH, Shoichet MS, Radisic M (2008) Vascular endothelial growth factor immobilized in collagen scaffold apromotes penetration and proliferation of endothelial cells. Acta Biomater 4: 477-489.
9. Soker S, Gollamudi-Payne S, Fidder H, Charmahelli H, Klagsbrun M (1997) Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J Biol Chem 272(50): 31582-31588.
10. Sulpice E, Ding S, Muscatelli-Groux B, Bergé M, Han ZC, Plouet J, Tobelem G, Merkulova-Rainon T (2009) Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell 101(9): 525-539.
11. Taguchi T, Kishida A, Akashi M, Maruyama I (2000) Immobilization of human vascular endothelial growth factor (VEGF165) onto biomaterials: an evaluation of the biological activity of immobilized VEGF165. J Bioactive Compat Polym 15: 309-320.